{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:13:44Z","timestamp":1790626424539,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","award":["PHRC I 2013"],"award-info":[{"award-number":["PHRC I 2013"]}],"id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00467-022-05636-9","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T08:04:43Z","timestamp":1656317083000},"page":"697-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study"],"prefix":"10.1007","volume":"38","author":[{"given":"Louisa","family":"Bloudeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Flammier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Portefaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa","family":"Eddiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Barosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Porquet-Bordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Rothenbuhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"5636_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, Biosse Duplan M et al (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15:435\u2013455. https:\/\/doi.org\/10.1038\/s41581-019-0152-5","journal-title":"Nat Rev Nephrol"},{"key":"5636_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.01.006","author":"J Bacchetta","year":"2019","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D (2019) Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metabolism. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006","journal-title":"Metabolism"},{"key":"5636_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/jbmr.3614","volume":"34","author":"A Rothenbuhler","year":"2019","unstructured":"Rothenbuhler A, Fadel N, Debza Y, Bacchetta J et al (2019) High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR). J Bone Miner Res 34:490\u2013496. https:\/\/doi.org\/10.1002\/jbmr.3614","journal-title":"J Bone Miner Res"},{"key":"5636_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab282","author":"H Kato","year":"2021","unstructured":"Kato H, Koga M, Kinoshita Y, Taniguchi Y et al (2021) Incidence of complications in 25 adult patients with X-linked hypophosphatemia. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgab282","journal-title":"J Clin Endocrinol Metab"},{"key":"5636_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A et al (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174:325\u2013333. https:\/\/doi.org\/10.1530\/EJE-15-0661","journal-title":"Eur J Endocrinol"},{"key":"5636_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1530\/EC-19-0481","volume":"9","author":"VV Zhukouskaya","year":"2020","unstructured":"Zhukouskaya VV, Rothenbuhler A, Colao A, Di Somma C et al (2020) Increased prevalence of overweight and obesity in children with X-linked hypophosphatemia. Endocr Connect 9:144\u2013153. https:\/\/doi.org\/10.1530\/EC-19-0481","journal-title":"Endocr Connect"},{"key":"5636_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/s-2002-33256","volume":"34","author":"W Xie","year":"2002","unstructured":"Xie W, M\u00e9chin M-C, Dubois SG, Lajeunesse D et al (2002) Up-regulation of liver glucose-6-phosphatase in x-linked hypophosphatemic mice. Horm Metab Res Horm Stoffwechselforschung Horm Metab 34:288\u2013292. https:\/\/doi.org\/10.1055\/s-2002-33256","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"5636_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/joim.12580","volume":"281","author":"A Kharitonenkov","year":"2017","unstructured":"Kharitonenkov A, DiMarchi R (2017) Fibroblast growth factor 21 night watch: advances and uncertainties in the field. J Intern Med 281:233\u2013246. https:\/\/doi.org\/10.1111\/joim.12580","journal-title":"J Intern Med"},{"key":"5636_CR9","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1210\/en.2009-0532","volume":"150","author":"MK Badman","year":"2009","unstructured":"Badman MK, Koester A, Flier JS, Kharitonenkov A et al (2009) Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150:4931\u20134940. https:\/\/doi.org\/10.1210\/en.2009-0532","journal-title":"Endocrinology"},{"key":"5636_CR10","doi-asserted-by":"publisher","first-page":"601349","DOI":"10.3389\/fendo.2020.601349","volume":"11","author":"E Henriksson","year":"2020","unstructured":"Henriksson E, Andersen B (2020) FGF19 and FGF21 for the treatment of NASH-two sides of the same coin? Differential and overlapping effects of FGF19 and FGF21 from mice to human. Front Endocrinol 11:601349. https:\/\/doi.org\/10.3389\/fendo.2020.601349","journal-title":"Front Endocrinol"},{"key":"5636_CR11","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"Carpenter TO, Insogna KL, Zhang JH, Ellis B et al (2010) Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95:E352-357. https:\/\/doi.org\/10.1210\/jc.2010-0589","journal-title":"J Clin Endocrinol Metab"},{"key":"5636_CR12","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1111\/apa.14907","volume":"108","author":"J Bacchetta","year":"2019","unstructured":"Bacchetta J, Ginhoux T, Bernoux D, Dubourg L et al (2019) Assessment of mineral and bone biomarkers highlights a high frequency of hypercalciuria in asymptomatic healthy teenagers. Acta Paediatr 108:2253\u20132260. https:\/\/doi.org\/10.1111\/apa.14907","journal-title":"Acta Paediatr"},{"key":"5636_CR13","unstructured":"https:\/\/www.bcm.edu\/bodycomplab\/Flashapps\/BPVAgeChartpage.html"},{"key":"5636_CR14","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, Boot AM et al (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378:1987\u20131998. https:\/\/doi.org\/10.1056\/NEJMoa1714641","journal-title":"N Engl J Med"},{"key":"5636_CR15","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832\u20131843. https:\/\/doi.org\/10.2215\/CJN.01640309","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"5636_CR16","first-page":"584","volume":"5","author":"L Ardeshirpour","year":"2007","unstructured":"Ardeshirpour L, Cole DEC, Carpenter TO (2007) Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev 5(Suppl 1):584\u2013598","journal-title":"Pediatr Endocrinol Rev"},{"key":"5636_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1467-789X.2009.00697.x","volume":"11","author":"SM Quinn","year":"2010","unstructured":"Quinn SM, Baur LA, Garnett SP, Cowell CT (2010) Treatment of clinical insulin resistance in children: a systematic review. Obes Rev 11:722\u2013730. https:\/\/doi.org\/10.1111\/j.1467-789X.2009.00697.x","journal-title":"Obes Rev"},{"key":"5636_CR18","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1515\/cclm-2020-0460","volume":"58","author":"M-L Piketty","year":"2020","unstructured":"Piketty M-L, Brabant S, Souberbielle J-C, Maruani G et al (2020) FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference. Clin Chem Lab Med 58:e267\u2013e269. https:\/\/doi.org\/10.1515\/cclm-2020-0460","journal-title":"Clin Chem Lab Med"},{"key":"5636_CR19","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1210\/jc.2015-1551","volume":"100","author":"EA Imel","year":"2015","unstructured":"Imel EA, Zhang X, Ruppe MD, Weber TJ et al (2015) Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23. J Clin Endocrinol Metab 100:2565\u20132573. https:\/\/doi.org\/10.1210\/jc.2015-1551","journal-title":"J Clin Endocrinol Metab"},{"key":"5636_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351. https:\/\/doi.org\/10.1038\/36285","journal-title":"Nature"},{"key":"5636_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/gerona\/glz061","volume":"74","author":"A Cheikhi","year":"2019","unstructured":"Cheikhi A, Barchowsky A, Sahu A, Shinde SN et al (2019) Klotho: an elephant in aging research. J Gerontol A Biol Sci Med Sci 74:1031\u20131042. https:\/\/doi.org\/10.1093\/gerona\/glz061","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5636_CR22","doi-asserted-by":"publisher","first-page":"617842","DOI":"10.3389\/fcvm.2020.617842","volume":"7","author":"V Saar-Kovrov","year":"2020","unstructured":"Saar-Kovrov V, Donners MMPC, van der Vorst EPC (2020) Shedding of klotho: functional implications in chronic kidney disease and associated vascular disease. Front Cardiovasc Med 7:617842. https:\/\/doi.org\/10.3389\/fcvm.2020.617842","journal-title":"Front Cardiovasc Med"},{"key":"5636_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbrc.2011.09.117","volume":"414","author":"RE Forster","year":"2011","unstructured":"Forster RE, Jurutka PW, Hsieh J-C, Haussler CA et al (2011) Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochem Biophys Res Commun 414:557\u2013562. https:\/\/doi.org\/10.1016\/j.bbrc.2011.09.117","journal-title":"Biochem Biophys Res Commun"},{"key":"5636_CR24","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/pedi.13095","volume":"21","author":"ML Marcovecchio","year":"2020","unstructured":"Marcovecchio ML, Colombo M, Dalton RN, McKeigue PM et al (2020) Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes. Pediatr Diabetes 21:1322\u20131332. https:\/\/doi.org\/10.1111\/pedi.13095","journal-title":"Pediatr Diabetes"},{"key":"5636_CR25","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408. https:\/\/doi.org\/10.1172\/JCI46122","journal-title":"J Clin Invest"},{"key":"5636_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Smorodchenko A, Zeitz U et al (2014) FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6:744\u2013759. https:\/\/doi.org\/10.1002\/emmm.201303716","journal-title":"EMBO Mol Med"},{"key":"5636_CR27","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1093\/ndt\/gfy122","volume":"33","author":"J Bacchetta","year":"2018","unstructured":"Bacchetta J, Pelletier S (2018) Vitamin D deficiency is associated with mortality in maintenance dialysis: moving forward from epidemiology to clinical trials. Nephrol Dial Transplant 33:1679\u20131682","journal-title":"Nephrol Dial Transplant"},{"key":"5636_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jbmr.1740","volume":"28","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta J, Sea JL, Chun RF, Lisse TS et al (2013) Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28:46\u201355. https:\/\/doi.org\/10.1002\/jbmr.1740","journal-title":"J Bone Miner Res"},{"key":"5636_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1681\/ASN.2014101009","volume":"27","author":"M Chonchol","year":"2016","unstructured":"Chonchol M, Greene T, Zhang Y, Hoofnagle AN et al (2016) Low vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am Soc Nephrol 27:227\u2013237. https:\/\/doi.org\/10.1681\/ASN.2014101009","journal-title":"J Am Soc Nephrol"},{"key":"5636_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.13585","volume":"137","author":"N Hensel","year":"2016","unstructured":"Hensel N, Sch\u00f6n A, Konen T, L\u00fcbben V et al (2016) Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density. J Neurochem 137:756\u2013769. https:\/\/doi.org\/10.1111\/jnc.13585","journal-title":"J Neurochem"},{"key":"5636_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K et al (2016) Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int 90:985\u2013996. https:\/\/doi.org\/10.1016\/j.kint.2016.05.019","journal-title":"Kidney Int"},{"key":"5636_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","volume":"18","author":"US Alon","year":"2003","unstructured":"Alon US, Monzavi R, Lilien M, Rasoulpour M et al (2003) Hypertension in hypophosphatemic rickets\u2013role of secondary hyperparathyroidism. Pediatr Nephrol 18:155\u2013158. https:\/\/doi.org\/10.1007\/s00467-002-1044-6","journal-title":"Pediatr Nephrol"},{"key":"5636_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1507\/endocrj.EJ16-0199","volume":"64","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Takagi M, Takeda R, Miyai K et al (2017) Hypertension is a characteristic complication of X-linked hypophosphatemia. Endocr J 64:283\u2013289. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0199","journal-title":"Endocr J"},{"key":"5636_CR34","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","volume":"82","author":"R Nehgme","year":"1997","unstructured":"Nehgme R, Fahey JT, Smith C, Carpenter TO (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82:2450\u20132454. https:\/\/doi.org\/10.1210\/jcem.82.8.4181","journal-title":"J Clin Endocrinol Metab"},{"key":"5636_CR35","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00467-018-4180-3","volume":"34","author":"O Hern\u00e1ndez-Fr\u00edas","year":"2019","unstructured":"Hern\u00e1ndez-Fr\u00edas O, Gil-Pe\u00f1a H, P\u00e9rez-Rold\u00e1n JM, Gonzalez-Sanchez S et al (2019) Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia. Pediatr Nephrol 34:1077\u20131086. https:\/\/doi.org\/10.1007\/s00467-018-4180-3","journal-title":"Pediatr Nephrol"},{"key":"5636_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/07435800.2016.1242604","volume":"42","author":"Y Takashi","year":"2017","unstructured":"Takashi Y, Kinoshita Y, Hori M, Ito N et al (2017) Patients with FGF23-related hypophosphatemic rickets\/osteomalacia do not present with left ventricular hypertrophy. Endocr Res 42:132\u2013137. https:\/\/doi.org\/10.1080\/07435800.2016.1242604","journal-title":"Endocr Res"},{"key":"5636_CR37","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A et al (2016) 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 34:1887\u20131920. https:\/\/doi.org\/10.1097\/HJH.0000000000001039","journal-title":"J Hypertens"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05636-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T04:05:10Z","timestamp":1673841910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05636-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5636"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05636-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JB and JPS received travel fees and consultant\/speaker fees from Kyowa Kirin. JB is an investigator for clinical trials for Kyowa Kirin. AL is an investigator for clinical trials for Kyowa Kirin and her research team receives research grants from Kyowa Kirin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}